Patent · US Active

Method for delivering drugs to the brain

US9044381B2 · kind B2 · utility

1Cited by
39References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 15, 2004
Grant dateJun 2, 2015
Priority date
Expiry dateJul 26, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/6901
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is concerned with delivering a pharmaceutical composition to the brain of a mammalian subject for treating brain diseases or disorders. The process includes the steps of: (i) providing a dispersion of the pharmaceutical composition as particles having an average particle size of from about 150 nm to about 100 microns, and (ii) administering the dispersion to the mammalian subject for delivery to the brain of a portion of the pharmaceutical composition by cells capable of reaching the brain. The dispersion of the pharmaceutical composition as particles, for example, can be phagocytized or adsorbed by the cells prior or subsequent to administration into the mammalian subject. The dispersion of the pharmaceutical composition can be administered to the central nervous system or the vascular system. After administration, the loaded cells transport the pharmaceutical composition as particles into the brain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.